Colorectal cancer treatment: Is Bevacizumab the best option?
@article{TGC965, author = {Luca Bagnasco and Daniela Piras}, title = {Colorectal cancer treatment: Is Bevacizumab the best option?}, journal = {Translational Gastrointestinal Cancer}, volume = {1}, number = {3}, year = {2012}, keywords = {}, abstract = {Colorectal cancer (CRC) is the third most common neoplastic disease worldwide and the second leading cause of cancer death in the western world (1).}, url = {https://tgc.amegroups.com/article/view/965} }